Pitolisant Hydrochloride | Harmony Biosciences LLC | ||
4.45 and 17.8 mg; Tablet |
Less Than $1000 mn
|
||
More Than 5
|
More Than 5
|
||
Less Than 5
|
None | ||
None | None | ||
Wakix is a histamine-3 (H3) receptor antagonist/inverse agonist indicated for the treatment of excessive daytime sleepiness (EDS) or cataplexy in adult patients with narcolepsy. | |||
Yes
|
Wakix | Patent 1 | Patent 2 | Patent 3 |
---|---|---|---|
***** | ******* | *** ********* | ******* |
******* ****** | **** ** *** **, **** | *** ********* | **** ** *** **, **** |
*** ************ | **** ** *** **, **** | *** ********* | **** ** *** **, **** |
Company | FTF Status / 180 days exclusivity | 30-Months stay | Current Litigation Status | Current Approval Status | Likelihood of launch |
---|---|---|---|---|---|
***** | *** \ ********* | *** **, **** | ******* | **** | ******* *** **** *** *** **** |
******* ****** | *** \ ********* | *** **, **** | ******* | **** | *** ****** *** **** |
*** ************ | *** \ ********* | *** **, **** | ******* | **** | *** ****** *** **** |